The people of Memorial Sloan Kettering Cancer Center (MSK) are united by a singular mission: ending cancer for life. Our specialized care teams provide personalized, compassionate, expert care to patients of all ages. Informed by basic research done at our Sloan Kettering Institute, scientists across MSK collaborate to conduct innovative translational and clinical research that is driving a revolution in our understanding of cancer as a disease and improving the ability to prevent, diagnose, and treat it. MSK is dedicated to training the next generation of scientists and clinicians, who go on to pursue our mission at MSK and around the globe.

Scientific Research Lead, CMO Innovation Lab

Exciting Opportunity at MSK: Are you passionate about molecular biology, next generation sequencing, and advancing molecular diagnostics? We are seeking a Scientific Research Lead to join the CMO Innovative Lab, where we develop and implement NGS-based molecular assays for use in the clinical lab at MSKCC.

In this pivotal role, you'll drive scientific innovation, mentor fellow lab members, participate in experimental design, and collaborate across groups to optimize and implement transformative approaches in NGS technologies. If you're excited by the challenge of translating cutting-edge molecular biology techniques into multi-omic clinical tests, we want to hear from you!

Role Overview:

• Lead scientific initiatives within the Innovation Lab, supporting high-impact research and development in areas such as DNA/RNA sequencing, epigenetics and proteomics.
• Collaborate with both wet- and dry-lab team members to analyze data and perform experimental design.
• Evaluate, implement, and optimize emerging technologies in the NGS space, including communication with outside research groups and vendors.
• Foster a productive and innovative environment for lab members to grow their projects through introduction of advanced techniques and scientific rigor.
• Collaborate with internal and external partners to drive translational research and technology development.
• Contribute to publications, grants, and presentations that shape the future of cancer diagnostics.

Key Qualifications:

• PhD in Molecular Biology or a related field (PhD + 4-7 years of relevant experience).
• Deep expertise in molecular biology, including experience with DNA- and RNA-based NGS workflows, methylation profiling and/or high-throughput proteomics.
• Demonstrated experience in data visualization and experimental design.
• Some knowledge of bioinformatics and experience working with sequencing data is highly desirable.
• Strong commitment to mentoring and collaborative science in an academic medical setting.

Core Skills:

• Leadership and communication skills to guide a dynamic research team.
• Analytical and critical thinking to support experimental design and lab operations.
• Proficiency in data analysis, and scientific software tools.
• Ability to lead complex projects and contribute to cross-functional initiatives.

Additional Information:

• Schedule: onsite daily, Monday - Friday, 37.5 hours
• Location: Zuckerman Research Building, 417 East 68th St.
• Reporting to: Manager

Helpful Links:

• Compensation Philosophy
• Benefits

#IHP

#LI-POST

Closing:

At MSK, we believe in fair, competitive pay that reflects your job, experience, and skills.

MSK is an equal opportunity and affirmative action employer committed to diversity and inclusion in all aspects of recruiting and employment. All qualified individuals are encouraged to apply and will receive consideration without regard to race, color, gender, gender identity or expression, sexual orientation, national origin, age, religion, creed, disability, veteran status or any other factor which cannot lawfully be used as a basis for an employment decision.

Federal law requires employers to provide reasonable accommodation to qualified individuals with disabilities. Please tell us if you require a reasonable accommodation to apply for a job or to perform your job. Examples of reasonable accommodation include making a change to the application process or work procedures, providing documents in an alternate format, using a sign language interpreter, or using specialized equipment.